Lidocaine nonclinical toxicology
From Wikidoc - Reading time: 1 min
| Lidocaine |
|---|
| XYLOCAINE® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Lidocaine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Nonclinical Toxicology[edit | edit source]
Carcinogenesis, Mutagenesis, Impairment of Fertility
Long term studies in animals to evaluate the carcinogenic and mutagenic potential or the effect on fertility of Xylocaine have not been conducted.[1]
References[edit | edit source]
Adapted from the FDA Package Insert.
Licensed under CC BY-SA 3.0 | Source: https://www.wikidoc.org/index.php/Lidocaine_nonclinical_toxicology8 views | Status: cached on August 11 2024 11:41:26↧ Download this article as ZWI file
EncycloReader
is supported by the 
KSF